Hypoxic-Ischaemic Encephalopathy Recruiting Phase 3 Trials for Allopurinol (DB00437)

Also known as: Encephalopathy, Hypoxic-Ischemic / Hypoxic-Ischemic Encephalopathy / Hypoxic ischemic encephalopathy [HIE], unspecified / Hypoxic ischemic brain injury

IndicationStatusPhase
DBCOND0080116 (Hypoxic-Ischaemic Encephalopathy)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03162653Effect of Allopurinol for Hypoxic-ischemic Brain Injury on Neurocognitive OutcomeTreatment